Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)
A phase 2/3 trial of Adebrelimab and SHR-A2102 in bladder & urothelial cancer, run by Suzhou Suncadia Biopharmaceuticals Co., Ltd., now recruiting.
Overview
Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316) is a phase 2/3 interventional study registered as NCT06879145 by Suzhou Suncadia Biopharmaceuticals Co., Ltd., with 840 participants planned, started 2025-04-25 and due to reach its primary completion in 2031-12. Interventions recorded: SHR-A2102；Adebrelimab.
Similar pages
not linked directly; found by shared links- TrialA Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
Shares SHR-A2102, Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Bladder & urothelial cancer and the tag pipeline.
- TrialA Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma
Shares SHR-A2102, Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Bladder & urothelial cancer and the tag pipeline.
- TrialA Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer
Shares SHR-A2102, Adebrelimab, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.
- TrialA Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant Tumour
Shares SHR-A2102, Adebrelimab, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.
- TrialA Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors
Shares SHR-A2102, Adebrelimab, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.
- TrialA Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy
Shares SHR-A2102, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.
- TrialA Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.
- TrialHRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals and the tag pipeline.